Inventor · disambiguated record
Guocheng Wang
Also filed as: WANG GUOCHENG
15 granted patents·7 pending applications·17 citations·filing 2000–2022
86Inventor score
Files withJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD15CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD2HARBIN HUAER CHEMICAL COMPANY1JIANGSU AUTOPARTS NEW ENERGY TECH CO LTD1MA XIAOHUI1
Top patents by PatentIndex Score
22 records- 0167US7417036B2Crystal form of adefovir dipivoxil and its preparationTIANJIN KINSLY PHARMACEUTICAL·Filed 2003·Granted Aug 26, 2008·9 cites·7 claims
- 0259US2021179632A1Thienopiperidine derivative and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0357US10071989B2Substituted cinnamamide derivative, preparation method and use thereofMA XIAOHUI·Filed 2012·Granted Sep 11, 2018·1 cites·10 claims
- 0457US7241367B1Permeable membrane diaphragm of different layers for electroytic cellsHARBIN HUAER CHEMICAL COMPANY·Filed 2000·Granted Jul 10, 2007·7 cites·8 claims
- 0556US12486259B2FXR agonist having pyrazine structure, and preparation method and useJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 2, 2025·0 cites·11 claims
- 0655US9714250B2Crystalline forms of temozolomide and the method for preparing sameJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 25, 2017·0 cites·9 claims
- 0755US2024190875A1Spiroindoline derivative, and preparation method and medical use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0851US2024228501A1Imidazole-containing condensed ring derivative, preparation method therefor, and application thereof in medicineCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0950US10745434B2Uridine phosphoramide prodrug, preparation method therefor, and medicinal uses thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 18, 2020·0 cites·5 claims
- 1049US2016200751A1Thienopiperidine derivative and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 1148US11130766B2Deuterated thienopiperidine derivatives, manufacturing method, and application thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 28, 2021·0 cites·4 claims
- 1246US10233202B2Tenofovir monobenzyl ester phosphamide prodrug, preparation method and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·20 claims
- 1346US8431577B2Crystalline form of eszopiclone, composition, preparation and uses thereofWANG GUOCHENG·Filed 2009·Granted Apr 30, 2013·0 cites·8 claims
- 1445US11149016B2S-substituted-2-amino-3-mercaptopropionate derivative, preparation method and application thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 19, 2021·0 cites·8 claims
- 1545US2021226307A1Cell connection device and battery comprising the cell connection deviceJIANGSU AUTOPARTS NEW ENERGY TECH CO LTD·Filed 2018·Application pending·0 cites
- 1645US2018338918A1Temsirolimus liposome and preparation method thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1743US10253007B2Taxanes compounds, preparation method therefor, and uses thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Granted Apr 9, 2019·0 cites·14 claims
- 1843US9890175B2Taxane compound, and preparation method and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Granted Feb 13, 2018·0 cites·11 claims
- 1937US2018153848A1Cabazitaxel fat emulsion, and preparation method and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2035US10005757B2Revaprazan hydrochloride polymorphs and preparation method thereforJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 26, 2018·0 cites·23 claims
- 2129US10358449B2Xanthine derivativeJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 23, 2019·0 cites·19 claims
- 2224US9981917B2Preparation method for revaprazan hydrochlorideJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2015·Granted May 29, 2018·0 cites·30 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →